For our patients overall, the presence of RP-ILD, dyspnea, and manifestations of UIP were independent risk factors for poor prognosis, although patients with a disease duration greater than 6 months, ANA positivity, and arthralgia had a better prognosis. This evidence concerns the gene BTG3 and interstitial lung disease.